- Home
- FBK vs MLTX Comparison
FBK vs MLTX Comparison
Compare FBK & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBK
- MLTX
- Stock Information
- Founded
- FBK 1906
- MLTX 2021
- Country
- FBK United States
- MLTX Switzerland
- Employees
- FBK N/A
- MLTX N/A
- Industry
- FBK Major Banks
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- FBK Finance
- MLTX Health Care
- Exchange
- FBK Nasdaq
- MLTX Nasdaq
- Market Cap
- FBK 2.1B
- MLTX 2.4B
- IPO Year
- FBK 2016
- MLTX N/A
- Fundamental
- Price
- FBK $43.56
- MLTX $39.01
- Analyst Decision
- FBK Hold
- MLTX Strong Buy
- Analyst Count
- FBK 5
- MLTX 8
- Target Price
- FBK $54.00
- MLTX $77.71
- AVG Volume (30 Days)
- FBK 200.0K
- MLTX 301.3K
- Earning Date
- FBK 07-14-2025
- MLTX 05-12-2025
- Dividend Yield
- FBK 1.74%
- MLTX N/A
- EPS Growth
- FBK 14.69
- MLTX N/A
- EPS
- FBK 2.73
- MLTX N/A
- Revenue
- FBK $465,280,000.00
- MLTX N/A
- Revenue This Year
- FBK $35.47
- MLTX $103.42
- Revenue Next Year
- FBK $20.14
- MLTX N/A
- P/E Ratio
- FBK $15.99
- MLTX N/A
- Revenue Growth
- FBK 2.18
- MLTX N/A
- 52 Week Low
- FBK $34.50
- MLTX $31.42
- 52 Week High
- FBK $58.88
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- FBK 45.57
- MLTX 50.57
- Support Level
- FBK $43.19
- MLTX $37.79
- Resistance Level
- FBK $44.56
- MLTX $40.71
- Average True Range (ATR)
- FBK 0.79
- MLTX 1.78
- MACD
- FBK -0.20
- MLTX -0.02
- Stochastic Oscillator
- FBK 14.60
- MLTX 58.61
About FBK FB Financial Corporation
FB Financial Corp is a bank holding company. The company through its wholly-owned bank subsidiary provides commercial and consumer banking services to clients in select markets in Tennessee, North Alabama, and North Georgia. The company segment includes Banking and Mortgage. It generates revenue from the Banking segment which provides a full range of deposit and lending products and services to corporate, commercial, and consumer customers. The Mortgage segment includes the servicing of residential mortgage loans and the packaging and securitization of loans to governmental agencies.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.